best performing large cap stocks from april 2014 through march 2015

Neurocrine Biosciences (NBIX) had the highest return between April 1, 2014 and March 31, 2015 by a large-cap US stock, returning 145.7%.

ASSETDATE% RETURN
Neurocrine Biosciences (NBIX)
4/1/2014 - 3/31/2015
145.73%
Centene (CNC)
4/1/2014 - 3/31/2015
124.73%
Palo Alto Networks (PANW)
4/1/2014 - 3/31/2015
107.21%
Electronic Arts (EA)
4/1/2014 - 3/31/2015
101.92%
Burlington Stores (BURL)
4/1/2014 - 3/31/2015
101.56%
Broadcom (AVGO)
4/1/2014 - 3/31/2015
99.55%
Ensign (ENSG)
4/1/2014 - 3/31/2015
98.97%
Leonardo DRS, Inc Common Stock (DRS)
4/1/2014 - 3/31/2015
98.63%
Monster Beverage (MNST)
4/1/2014 - 3/31/2015
98.44%
Edwards Lifesciences (EW)
4/1/2014 - 3/31/2015
90.53%
Super Micro Computer (SMCI)
4/1/2014 - 3/31/2015
89.99%
Southwest Airlines (LUV)
4/1/2014 - 3/31/2015
88%
Advanced Drainage Systems (WMS)
4/1/2014 - 3/31/2015
87.15%
Genmab A-S (GMAB)
4/1/2014 - 3/31/2015
82.37%
Biomarin Pharmaceutical (BMRN)
4/1/2014 - 3/31/2015
81.85%
Tower Semiconductor (TSEM)
4/1/2014 - 3/31/2015
81.8%
MACOM Technology Solutions (MTSI)
4/1/2014 - 3/31/2015
81.31%
United Therapeutics (UTHR)
4/1/2014 - 3/31/2015
81.26%
CoreSite Realty (COR)
4/1/2014 - 3/31/2015
78.65%
Kroger (KR)
4/1/2014 - 3/31/2015
77.52%
Incyte (INCY)
4/1/2014 - 3/31/2015
70.47%
NXP Semiconductors (NXPI)
4/1/2014 - 3/31/2015
70.13%
Vertex Pharmaceuticals (VRTX)
4/1/2014 - 3/31/2015
65.41%
Apple (AAPL)
4/1/2014 - 3/31/2015
65.04%
ResMed (RMD)
4/1/2014 - 3/31/2015
63.9%
Large-cap stocks are treated as having a market cap of $10B+.